HK:8329 Shenzhen Neptunus Interlong Bio-technique Company Limited

Shenzhen Neptunus Interlong Bio-technique Company Limited researches, develops, produces, and sells medicines in the People's Republic of China. It is also involved in the purchase and sales of medicines and healthcare food products; research and development of modern biological technology products and in vitro diagnostic reagents. The company markets its products under the Neptunus and Interlong brand names. It sells its products in approximately 20 provinces in China; and serves approximately 500 medical organizations. The company is based in Shenzhen, the People's Republic of China. Shenzhen Neptunus Interlong Bio-technique Company Limited is a subsidiary of Shenzhen Neptunus Bio-engineering Company Limited.

0.24 HKD
As of 11/30/2021


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Drug Manufacturers-Specialty &
Index country:  China
Country of incorporation:  China
IPO date:  09/12/2005
Stock exchange:    Hong Kong Exchange
Exchange country:   Hong Kong
Market cap:   389,296,000 HKD
Current dividend yield:   0.00%
CUSIP:    
ISIN:        CNE100000775
Sedol:      

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy